The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | Common | 004225108 | 17,130 | 614,200 | SH | SOLE | 614,200 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | Common | 00771V108 | 12,131 | 230,842 | SH | SOLE | 230,842 | 0 | 0 | ||
AGENUS INC | Common | 00847G705 | 12,449 | 3,183,828 | SH | SOLE | 3,183,828 | 0 | 0 | ||
ALIMERA SCIENCES INC | Common | 016259103 | 8,189 | 5,891,581 | SH | SOLE | 5,891,581 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 59,725 | 5,930,956 | SH | SOLE | 5,930,956 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 532 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
ARGENX SE | Sponsored ADR | 04016X101 | 4,573 | 215,597 | SH | SOLE | 215,597 | 0 | 0 | ||
ARRAY BIOPHARMA INC | Common | 04269X105 | 34,948 | 4,175,376 | SH | SOLE | 4,175,376 | 0 | 0 | ||
ARRAY BIOPHARMA INC | Common | 04269X105 | 587 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 27,508 | 990,924 | SH | SOLE | 990,924 | 0 | 0 | ||
ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 12,538 | 607,162 | SH | SOLE | 607,162 | 0 | 0 | ||
AVEO PHARMACEUTICALS INC | Common | 053588109 | 14,724 | 6,632,452 | SH | SOLE | 6,632,452 | 0 | 0 | ||
AXOVANT SCIENCES LTD | Common | G0750W104 | 1,904 | 82,087 | SH | SOLE | 82,087 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 10,862 | 1,953,525 | SH | SOLE | 1,953,525 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 45,482 | 500,789 | SH | SOLE | 500,789 | 0 | 0 | ||
CASCADIAN THERAPEUTICS INC | Common | 14740B606 | 6,766 | 1,821,248 | SH | SOLE | 1,821,248 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | Common | 14888U101 | 10,501 | 3,804,745 | SH | SOLE | 3,804,745 | 0 | 0 | ||
CELLECTIS - ADR | Sponsored ADR | 15117K103 | 2,212 | 85,689 | SH | SOLE | 85,689 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | Common | 189464100 | 13,174 | 140,700 | SH | SOLE | 140,700 | 0 | 0 | ||
DERMIRA INC | Common | 24983L104 | 38,611 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | ||
FORTRESS BIOTECH INC | Common | 34960Q109 | 2,867 | 603,657 | SH | SOLE | 603,657 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS INC | Common | 37890U108 | 23,521 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | ||
IMMUNOMEDICS INC | Common | 452907108 | 92,610 | 10,488,076 | SH | SOLE | 10,488,076 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 30,512 | 4,151,343 | SH | SOLE | 4,151,343 | 0 | 0 | ||
KITE PHARMA INC | Common | 49803L109 | 83,636 | 806,750 | SH | SOLE | 806,750 | 0 | 0 | ||
MEDICINES CO | Common | 584688105 | 42,157 | 1,109,100 | SH | SOLE | 1,109,100 | 0 | 0 | ||
MEDICINES CO | Common | 584688105 | 20 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
MEDICINES CO | Common | 584688105 | 30 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
MIRATI THERAPEUTICS INC | Common | 60468T105 | 8,305 | 2,275,401 | SH | SOLE | 2,275,401 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | Common | 64125C109 | 10,097 | 219,500 | SH | SOLE | 219,500 | 0 | 0 | ||
NEURODERM LTD | Common | M74231107 | 1,331 | 44,516 | SH | SOLE | 44,516 | 0 | 0 | ||
NEVRO CORP | Common | 64157F103 | 3,722 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ONCOBIOLOGICS INC | Common | 68235M105 | 684 | 683,531 | SH | SOLE | 683,531 | 0 | 0 | ||
ONCOBIOLOGICS INC - WARRANT A | Warrant | 68235M113 | 40 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
ONCOBIOLOGICS INC - WARRANT B | Warrant | 68235M121 | 22 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
OVASCIENCE INC | Common | 69014Q101 | 489 | 313,316 | SH | SOLE | 313,316 | 0 | 0 | ||
PACIRA PHARMACEUTICALS INC | Common | 695127100 | 22,220 | 465,818 | SH | SOLE | 465,818 | 0 | 0 | ||
PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 1,859 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
PTC THERAPEUTICS | Common | 69366J200 | 2,200 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
SPDR S&P 500 ETF | Put | 78462F953 | 1,456 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
SANGAMO THERAPEUTICS INC | Common | 800677106 | 7,040 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
SORRENTO THERAPEUTICS INC | Common | 83587F202 | 832 | 416,230 | SH | SOLE | 416,230 | 0 | 0 | ||
TELIGENT INC | Common | 87960W104 | 37,797 | 4,130,800 | SH | SOLE | 4,130,800 | 0 | 0 | ||
TESARO INC | Common | 881569107 | 56,000 | 400,403 | SH | SOLE | 400,403 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | Common | 921659108 | 14,705 | 902,146 | SH | SOLE | 902,146 | 0 | 0 | ||
VERACYTE INC | Common | 92337F107 | 7,560 | 907,596 | SH | SOLE | 907,596 | 0 | 0 | ||
VIVEVE MEDICAL INC | Common | 92852W204 | 5,712 | 795,500 | SH | SOLE | 795,500 | 0 | 0 |